A new case series reveals how targeted dietary supplements can improve lipid profiles, cognitive function, and overall ...

Researcher shows that it's not just fatty food which can send bad cholesterol levels soaring - some drinks need to be avoided ...

Zydus Lifesciences rose 1.02% to Rs 897 after the pharma company received final approval from the US Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg , ...

Among adults with thyroid cancer, those with hypoparathyroidism after a thyroidectomy may have increased risk for several ...

A new study published in the journal of Cureus showed that nearly three out of four psoriasis patients had dyslipidemia, ...

A pot belly indicates serious health issues beyond appearance. Doctors in India link it to heart problems, liver issues, and ...

Virtually all studies have shown very high safety profiles for nutritional supplements in the treatment of dyslipidemia. In the section below, all the efficacy studies, adverse effects and safety ...

We aim to comprehensively evaluate the safety of using inclisiran in patients with dyslipidemia and ASCVD or ASCVD risk equivalent. Methods: Four electronic databases of Pubmed/MEDLINE, Web of Science ...

With no endometriosis as our reference, we evaluated the associations between endometriosis diagnosis, stage (I/II vs III/IV), and typology (SE, OE, DE, OE+DE) and dyslipidemia using standard clinical ...

Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 12.32%, which has investors questioning if this is right ...

In this Review, the theory presents new pathways for disease-modifying therapies in T1D that focus on preventing early-phase dyslipidemia. It is hoped that including this theoretical framework in ...